Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Immediate Breast Reconstructions after Mastectomy due to Breast Cancers with the Use of Serasynth and Seragynbr Synthetic Meshes. Single-Oncological Center Experience, Analysis of Complications

Aleksander Grous, Slawomir Mazur, Pawel Winter, Krzysztof Kozak, Agnieszka Jagiello- Gruszfeld, Marcin Napierala, Zbigniew Nowecki

Purpose: Mastectomies with immediate reconstruction are the standard of treatment method in patients with breast cancer who cannot be treated with conserving breast surgery. The use of meshes in reconstructive breast surgery has become a gold standard. The purpose of the study was to analyse the complications and own experience after mastectomies with immediate breast reconstruction with the use of Serasynth and SeragynBR synthetic meshes.

Methods: In the period from December 2017 to July 2020, 118 reconstructive surgeries of the breast were performed in the Department of Breast Cancer and Reconstructive Surgery in Maria Sklodowska – Curie Memorial Cancer Center and Institute of Oncology in Warsaw, Poland with the use of SeragynBR and Serasynth meshes in 93 patients operated for breast cancer. 78 Serasynth meshes (Group1) and 40 SeragynBR meshes (Group1I) were implanted.

Results: The most common complication was persistent seroma collection, which was reported in 17.9% of cases in Group1 and 25% in Group1I. Skin inflammation was reported in 7.6% and 17.5%, while infections in 2.5% and 5% of the surgically treated breasts of Group1 and Group2 patients. Reoperation was required in 5.1% and 5% of the patients in Group1 and Group2. The percentage of complications was lower when Serasynth rather than Seragyn BR meshes were implanted. The frequent incidence of the seroma collection did not contribute in any significant way to serious complications such as the need for removal of mesh/implant or infection. The complications, which developed following the implantation of both mesh types, were similar to those presented in other publications concerning mastectomy with a simultaneous breast reconstruction with synthetic meshes. The percentage of implant losses/explanations in the discussed group of patients was lower than that reported in literature.

Conclusion: Despite the complications, both types of meshes can be considered as safe additions to reconstructive breast surgeries.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert.